Showing results (261-270 of 298) with videos related to
Sort By:
Pageof 30
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 28, 2014
Patterns of viral load decline with telaprevir-based therapy in patients with genotype 1 chronic HCV infectionGaston Picchio, Sandra De Meyer, Inge Dierynck, et al.Neuropharmacology|April 13, 2020
NOP receptor agonist attenuates nitroglycerin-induced migraine-like symptoms in miceKatarzyna M Targowska-Duda, Akihiko Ozawa, Zachariah Bertels, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 16, 1998
Activity of the delta-opioid receptor is partially reduced, whereas activity of the kappa-receptor is maintained in mice lacking the mu-receptorH W Matthes, C Smadja, O Valverde, et al.Journal of Virology|November 16, 2012
Hepatitis C virus variants with decreased sensitivity to direct-acting antivirals (DAAs) were rarely observed in DAA-naive patients prior to treatmentDoug J Bartels, James C Sullivan, Eileen Z Zhang, et al.Gastroenterology|May 9, 2007
Dynamic hepatitis C virus genotypic and phenotypic changes in patients treated with the protease inhibitor telaprevirChristoph Sarrazin, Tara L Kieffer, Doug Bartels, et al.Plos Computational Biology|August 8, 2014
Modeling viral evolutionary dynamics after telaprevir-based treatmentEric L Haseltine, Sandra De Meyer, Inge Dierynck, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 25, 2012
In vivo visualization of delta opioid receptors upon physiological activation uncovers a distinct internalization profileLauren Faget, Eric Erbs, Julie Le Merrer, et al.Iscience|March 30, 2019
Biased Signaling of the Mu Opioid Receptor Revealed in Native NeuronsAliza T Ehrlich, Meriem Semache, Florence Gross, et al.Journal of Virological Methods|March 31, 2015
A comparison of 454 sequencing and clonal sequencing for the characterization of hepatitis C virus NS3 variantsCynthia K Y Ho, Matthijs R A Welkers, Xiomara V Thomas, et al.Plos One|August 1, 2012
Evaluation of persistence of resistant variants with ultra-deep pyrosequencing in chronic hepatitis C patients treated with telaprevirXiomara V Thomas, Joep de Bruijne, James C Sullivan, et al.Pageof 30